BioNTech SE (BNTX) Tax Rate (2018 - 2025)

BioNTech SE (BNTX) posted Tax Rate of 34.12% for Q4 2025, up 115.78% sequentially from 216.19% in Q3 2025, and up 4797.0% YoY from 0.7% in Q4 2024.

BioNTech SE (BNTX) Tax Rate (2018 - 2025) Analysis & Trends

BioNTech SE has reported Tax Rate for 8 years, with the latest figure at 34.12% in Q4 2025.

Quarterly Tax Rate rose 4797.0% year-over-year to 34.12% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 8.91% (up 1092.0% YoY) and the FY2025 annual result came in at 8.12%, down 995.0% from the prior year.
Tax Rate climbed to 34.12% in Q4 2025 per BNTX's latest filing, from 216.19% in the prior quarter.
Over five years, Tax Rate peaked at 34.12% in Q4 2025 and troughed at 216.19% in Q3 2025.
A 5-year average of 28.26% and a median of 28.04% in 2022 frame the typical range for Tax Rate.
The sharpest annual moves came in 2024 and 2025: Tax Rate soared 5420 bps in 2024, then tumbled 24102 bps in 2025.
Over 5 years, Tax Rate stood at 32.83% in 2021, then advanced by 14 bps to 28.18% in 2022, then retreated by 10 bps to 30.96% in 2023, then soared by 55 bps to 13.84% in 2024, then surged by 346 bps to 34.12% in 2025.
According to Business Quant data, Tax Rate over the past three periods registered 34.12%, 216.19%, and 4.0% for Q4 2025, Q3 2025, and Q2 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	20.98%
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	15.11%
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	10.91%
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	24.15%
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-9.47%
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	7.49%
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-16.71%
10	BioNTech SE	23.54 Bn	5.15 Bn	668.28 Mn	34.12%

Download Data